Literature DB >> 18562096

No association of SORL1 SNPs with Alzheimer's disease.

Ryan L Minster1, Steven T DeKosky, M Ilyas Kamboh.   

Abstract

SORL1 is an element of the amyloid precursor protein processing pathway and is therefore a good candidate for affecting Alzheimer's disease (AD) risk. Indeed, there have been reports of associations between variation in SORL1 and AD risk. We examined six statistically significant single-nucleotide polymorphisms from the initial observation in a large Caucasian American case-controls cohort (1000 late-onset AD [LOAD] cases and 1000 older controls). Analysis of allele, genotype and haplotype frequencies revealed no association with LOAD risk in our cohort.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562096      PMCID: PMC2519047          DOI: 10.1016/j.neulet.2008.05.082

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

1.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.

Authors:  Ekaterina Rogaeva; Yan Meng; Joseph H Lee; Yongjun Gu; Toshitaka Kawarai; Fanggeng Zou; Taiichi Katayama; Clinton T Baldwin; Rong Cheng; Hiroshi Hasegawa; Fusheng Chen; Nobuto Shibata; Kathryn L Lunetta; Raphaelle Pardossi-Piquard; Christopher Bohm; Yosuke Wakutani; L Adrienne Cupples; Karen T Cuenco; Robert C Green; Lorenzo Pinessi; Innocenzo Rainero; Sandro Sorbi; Amalia Bruni; Ranjan Duara; Robert P Friedland; Rivka Inzelberg; Wolfgang Hampe; Hideaki Bujo; You-Qiang Song; Olav M Andersen; Thomas E Willnow; Neill Graff-Radford; Ronald C Petersen; Dennis Dickson; Sandy D Der; Paul E Fraser; Gerold Schmitt-Ulms; Steven Younkin; Richard Mayeux; Lindsay A Farrer; Peter St George-Hyslop
Journal:  Nat Genet       Date:  2007-01-14       Impact factor: 38.330

2.  Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.

Authors:  Olav M Andersen; Juliane Reiche; Vanessa Schmidt; Michael Gotthardt; Robert Spoelgen; Joachim Behlke; Christine A F von Arnim; Tilman Breiderhoff; Pernille Jansen; Xin Wu; Kelly R Bales; Roberto Cappai; Colin L Masters; Jørgen Gliemann; Elliott J Mufson; Bradley T Hyman; Steven M Paul; Anders Nykjaer; Thomas E Willnow
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-07       Impact factor: 11.205

3.  The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments.

Authors:  Katrin Offe; Sara E Dodson; James T Shoemaker; Jason J Fritz; Marla Gearing; Allan I Levey; James J Lah
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

Review 4.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

5.  Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome.

Authors:  Joseph H Lee; Maruit Chulikavit; Deborah Pang; Warren B Zigman; Wayne Silverman; Nicole Schupf
Journal:  Neurosci Lett       Date:  2007-08-25       Impact factor: 3.046

6.  A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population.

Authors:  Fan Liu; Alejandro Arias-Vásquez; Kristel Sleegers; Yurii S Aulchenko; Manfred Kayser; Pascual Sanchez-Juan; Bing-Jian Feng; Aida M Bertoli-Avella; John van Swieten; Tatiana I Axenovich; Peter Heutink; Christine van Broeckhoven; Ben A Oostra; Cornelia M van Duijn
Journal:  Am J Hum Genet       Date:  2007-05-29       Impact factor: 11.025

7.  Role of genes and environments for explaining Alzheimer disease.

Authors:  Margaret Gatz; Chandra A Reynolds; Laura Fratiglioni; Boo Johansson; James A Mortimer; Stig Berg; Amy Fiske; Nancy L Pedersen
Journal:  Arch Gen Psychiatry       Date:  2006-02

8.  The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort.

Authors:  Joseph H Lee; Rong Cheng; Nicole Schupf; Jennifer Manly; Rafael Lantigua; Yaakov Stern; Ekaterina Rogaeva; Yosuke Wakutani; Lindsay Farrer; Peter St George-Hyslop; Richard Mayeux
Journal:  Arch Neurol       Date:  2007-04

9.  Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.

Authors:  A J Slooter; M Cruts; S Kalmijn; A Hofman; M M Breteler; C Van Broeckhoven; C M van Duijn
Journal:  Arch Neurol       Date:  1998-07

10.  GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.

Authors:  Eric M Reiman; Jennifer A Webster; Amanda J Myers; John Hardy; Travis Dunckley; Victoria L Zismann; Keta D Joshipura; John V Pearson; Diane Hu-Lince; Matthew J Huentelman; David W Craig; Keith D Coon; Winnie S Liang; RiLee H Herbert; Thomas Beach; Kristen C Rohrer; Alice S Zhao; Doris Leung; Leslie Bryden; Lauren Marlowe; Mona Kaleem; Diego Mastroeni; Andrew Grover; Christopher B Heward; Rivka Ravid; Joseph Rogers; Michael L Hutton; Stacey Melquist; Ron C Petersen; Gene E Alexander; Richard J Caselli; Walter Kukull; Andreas Papassotiropoulos; Dietrich A Stephan
Journal:  Neuron       Date:  2007-06-07       Impact factor: 17.173

View more
  17 in total

Review 1.  The genetics and neuropathology of Alzheimer's disease.

Authors:  Gerard D Schellenberg; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2012-05-23       Impact factor: 17.088

2.  Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markers.

Authors:  Panagiotis Alexopoulos; Liang-Hao Guo; Martina Kratzer; Christine Westerteicher; Alexander Kurz; Robert Perneczky
Journal:  Dement Geriatr Cogn Disord       Date:  2011-10-13       Impact factor: 2.959

3.  Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1.

Authors:  Ziran Wang; Hongyan Lei; Mei Zheng; Yuxin Li; Yansen Cui; Fang Hao
Journal:  Mol Neurobiol       Date:  2015-11-27       Impact factor: 5.590

4.  Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain.

Authors:  Karrie E Grear; I-Fang Ling; James F Simpson; Jennifer L Furman; Christopher R Simmons; Shawn L Peterson; Frederick A Schmitt; William R Markesbery; Qiang Liu; Julia E Crook; Steven G Younkin; Guojun Bu; Steven Estus
Journal:  Mol Neurodegener       Date:  2009-11-04       Impact factor: 14.195

Review 5.  Chipping away at diagnostics for neurodegenerative diseases.

Authors:  Clemens R Scherzer
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

6.  Sortilin receptor 1 predicts longitudinal cognitive change.

Authors:  Chandra A Reynolds; Catalina Zavala; Margaret Gatz; Loryana Vie; Boo Johansson; Bo Malmberg; Erik Ingelsson; Jonathan A Prince; Nancy L Pedersen
Journal:  Neurobiol Aging       Date:  2013-01-11       Impact factor: 4.673

7.  Sequence variation in SORL1 and dementia risk in Swedes.

Authors:  Chandra A Reynolds; Mun-Gwan Hong; Ulrika K Eriksson; Kaj Blennow; Boo Johansson; Bo Malmberg; Stig Berg; Margaret Gatz; Nancy L Pedersen; Anna M Bennet; Jonathan A Prince
Journal:  Neurogenetics       Date:  2009-08-04       Impact factor: 2.660

8.  Allelic mRNA expression of sortilin-1 (SORL1) mRNA in Alzheimer's autopsy brain tissues.

Authors:  Houda Alachkar; Maria Kataki; Douglas W Scharre; Audrey Papp; Wolfgang Sadee
Journal:  Neurosci Lett       Date:  2008-10-15       Impact factor: 3.046

Review 9.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

10.  Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.

Authors:  Gary W Beecham; Eden R Martin; Yi-Ju Li; Michael A Slifer; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2009-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.